Status
Conditions
Treatments
About
This randomized controlled double-blind parallel-group interventional trial explores the impact of 8-week creatine supplementation, with or without ubiquinol, on sperm quality biomarkers in normospermic and oligospermic men. It aims to determine potential enhancements in sperm health to provide insights into male fertility and reproductive health improvement strategies.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
18 participants in 3 patient groups, including a placebo group
There are currently no registered sites for this trial.
Central trial contact
Sergej Ostojic, MD, PhD
Start date
Dec 15, 2023 • 1 year and 4 months ago
End date
May 31, 2024 • 11 months ago
Today
May 07, 2025
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal